BOI:EPA
Boiron SA
18,15 €
0,00%
(0,00) 1D
20-окт., 09:29:37 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
18,15 €
High
18,15 €
Low
18,10 €
Mkt. cap
318,45 млн
Avg. vol.
5,50 миң
Volume
669,00
P/E ratio
12,03
52-wk high
32,00 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
Open
18,15 €
High
18,15 €
Low
18,10 €
Mkt. cap
318,45 млн
Avg. vol.
5,50 миң
Volume
669,00
P/E ratio
12,03
52-wk high
32,00 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
News stories
From web sources and news partners
Yahoo Finance
·
30 мүнөт мурун
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
The Arkansas Democrat-Gazette
·
35 мүнөт мурун
AI stocks recover some losses; rest of market shaky
FXStreet
·
34 мүнөт мурун
S&P 500: Tech rebound offsets broader weakness – Deutsche Bank
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2,62 миң
Founded1932-ж., 7-июн.
Headquarters-
SectorPharmaceutical industry
Websiteboiron.fr